Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve (a) The Unaudited Financial ....

Date: 4th August, 2026 BSE Limited National Stock Exchange of India Limited Dept. of Corporate Services, Dept. of Corporate Compliances, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block-G, Dalal Street, Bandra Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 BSE Scrip Code - 541304 NSE Symbol: INDOUS Dear Sir / Madam, Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 12th August, 2026, inter-alia, to consider the following agenda items: (a) The Unaudited Financial Results for the quarter ended on June 30, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; (b) Other corporate matters. Further, in continuation of our letter dated 29th June, 2026 and in terms of the Indo Us Bio Tech Limited, the trading window for insiders which is already closed with effect from 1st July, 2026, shall continue to remain closed till 48 (Forty Eight) hours after the dissemination of the un-audited Standalone financial results of the Company (both days inclusive) for quarter ended 30th June, 2026. Kindly take the same on record and acknowledge the receipt. Thanking you, Yours faithfully, For, Indo Us Bio Tech Limited Ms. Dimpy Joshi Company Secretary & Compliance Officer